KYOWA KIRIN CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-09-12
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT03280264
- Locations
- 🇯🇵
Osaka City University Hospital, Ōsaka, Japan
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia
- First Posted Date
- 2017-07-28
- Last Posted Date
- 2022-09-06
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT03233126
- Locations
- 🇯🇵
Kanagawa Prefectural Hospital Organization Kanagawa Children's Medical Center, Yokohama, Kanagwa, Japan
🇯🇵Osaka Hospital, Japan Community Healthcare Organization (JCHO), Ōsaka, Osaka, Japan
🇯🇵Okayama Saiseikai General Hospital Outpatient Center, Okayama, Japan
A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2017-06-19
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT03191526
- Locations
- 🇯🇵
Kansai Medical University Hosipital, Hirakata, Osaka Prefecture, Japan
🇯🇵University Hosipital, Kyoto Prefectural University of Medicine, Kyoto, Japan
🇯🇵University of the Ryukyus Hospital, Nakagami, Okinawa Prefecture, Japan
A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis
- First Posted Date
- 2017-03-30
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 26
- Registration Number
- NCT03096223
- Locations
- 🇯🇵
Closed information, Sapporo, Japan
A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease
- First Posted Date
- 2017-03-28
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT03093519
- Locations
- 🇯🇵
Closed information, Saitama, Japan
A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 155
- Registration Number
- NCT02985593
A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 159
- Registration Number
- NCT02985983
- Locations
- 🇯🇵
Tenri Hospital, Nara, Japan
🇯🇵Fukuoka University Hospital, Fukuoka, Japan
🇯🇵Kyusyu University Hospital, Fukuoka, Japan
A Study of KW-6356 in Subjects With Early Parkinson's Disease
- First Posted Date
- 2016-10-20
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 175
- Registration Number
- NCT02939391
Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 46
- Registration Number
- NCT02773290
Study of Benralizumab (KHK4563) in Patients With Eosinophilic Chronic Rhinosinusitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 63
- Registration Number
- NCT02772419
© Copyright 2024. All Rights Reserved by MedPath